IL-2-IN-1

CAS No. 245747-10-8

IL-2-IN-1( —— )

Catalog No. M35621 CAS No. 245747-10-8

IL-2-IN-1 is a potent inhibitor of IL-2 (IC50: 1978 nM) and demonstrates anti-proliferative effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 100 Get Quote
5MG 150 Get Quote
10MG 242 Get Quote
25MG 472 Get Quote
50MG 753 Get Quote
100MG 972 Get Quote
500MG 1971 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    IL-2-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    IL-2-IN-1 is a potent inhibitor of IL-2 (IC50: 1978 nM) and demonstrates anti-proliferative effects.
  • Description
    IL-2-IN-1 is a potent IL-2 inhibitor with an IC50 value of 1978 nM. IL-2-IN-1 shows antiproliferative activities.
  • In Vitro
    IL-2-IN-1 (compound 2) shows antiproliferative activities with IC50s of 340, 1266 nM for human PBMC and rat PBMC, respectively.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    IL Receptor
  • Recptor
    IL Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    245747-10-8
  • Formula Weight
    418.29
  • Molecular Formula
    C17H12F6N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC1=CC=C(C=C1)N2N=C(C=C2C(F)(F)F)C(F)(F)F)C=3C(=NOC3C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Djuric SW, et al. 3,5-Bis(trifluoromethyl)pyrazoles: a novel class of NFAT transcription factor regulator. J Med Chem. 2000 Aug 10;43(16):2975-81.?
molnova catalog
related products
  • (E)-Ferulic acid met...

    Methyl (E)-ferulate is a possible inhibitor of the mitogen activated phosphor kinase pathway, it could be a potential anti-inflammatory agent isolated for the first time in medicinal plant S. tuberosa. Methyl (E)-ferulate has promising anthelmintic activity against Haemonchus contortus.

  • Benralizumab

    Benralizumab (MEDI-563) is a monoclonal antibody targeting the interleukin-5 receptor alpha (IL-5Rα).

  • SDZ 224-015

    SDZ 224-015 is an orally active inhibitor of interleukin-1β (IL-1β) converting enzyme and caspase-1, exhibiting anti-COVID-19 and anti-inflammatory activity, and reducing carrageenan gum-induced paw edema in rats.